Stay updated on Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.

Latest updates to the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page
- Check5 days agoChange DetectedA new funding notice was added and the page revision was updated to v3.4.1 (replacing v3.4.0); these are administrative updates that do not affect study details.SummaryDifference0.6%

- Check13 days agoChange DetectedUI changes to the history page include color-coded diffs (green additions, red deletions with strikethroughs), a glossary toggle, and an updated revision label (v3.4.0) plus a No FEAR Act Data label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe revision history now shows a new version v3.3.4 and removes v3.3.3, reflecting routine version control for the page, and it does not affect the study content or current record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedNew revision entry v3.3.3 was added to the history, and HHS Vulnerability Disclosure and revision v3.3.2 were removed in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check77 days agoChange DetectedAdded a new page revision entry labeled v3.3.2 and removed the previous v3.2.0 from the history, reflecting internal versioning updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedRemoved the government funding/operating status banner from the page header of the NCT04128501 record. The notice previously appeared at the top of the ClinicalTrials.gov record.SummaryDifference0.5%

Stay in the know with updates to Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.